Pharmaceutical composition for use in the treatment of a neurodegenerative disease

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9364519
APP PUB NO 20130116179A1
SERIAL NO

13602913

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present application relates to a pharmaceutical composition for use in the prevention or/and treatment of a neurodegenerative disease, the composition comprising desPro36Exendin-4(1-39)-Lys6-NH2 or/and a pharmaceutically acceptable salt thereof, and optionally a pharmaceutically acceptable carrier, adjuvant, or/and auxiliary substance. In addition, the present application relates to the use of the pharmaceutical composition for the treatment and prevention of a neurodegenerative disease.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SANOFI-AVENTIS DEUTSCHLAND GMBH65929 FRANKFURT AM MAIN
UNIVERSITY OF ULSTERCROMORE ROAD COLERAINE BT52 1SA BT52 1SA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Boehme, Andrees Paris, FR 2 14
Hess, Sibylle Frankfurt am Main, DE 7 21
Hoelscher, Christian Northern Ireland, GB 3 14
Menut, Agnes Paris, FR 2 14
Pradier, Laurent Paris, FR 17 95
Taupin, Veronique Paris, FR 3 16

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 14, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00